{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:02:57Z","timestamp":1792011777621,"version":"4.4.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.13205","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T15:30:34Z","timestamp":1624030234000},"page":"e2113205","source":"Crossref","is-referenced-by-count":69,"title":["Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy"],"prefix":"10.1001","volume":"4","author":[{"given":"Xingzhe","family":"Li","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarin","family":"Kitpanit","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Mah","sequence":"additional","affiliation":[{"name":"ProCure Proton Therapy Center, Somerset, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sine","sequence":"additional","affiliation":[{"name":"ProCure Proton Therapy Center, Somerset, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara A.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren S.","family":"Michel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fetten","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Zakeri","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Julie","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna Y.","family":"Gelblum","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"McBride","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaojung J.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Riaz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"issue":"10192","key":"zoi210396r1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma.","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"zoi210396r2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi210396r3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"issue":"22","key":"zoi210396r4","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"zoi210396r5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma.","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"issue":"10054","key":"zoi210396r6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"zoi210396r7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic phase 2 consortium (NCI-9742).","volume":"36","author":"Ma","year":"2018","journal-title":"J Clin Oncol"},{"issue":"36","key":"zoi210396r8","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1200\/JCO.2017.73.3675","article-title":"Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 Study.","volume":"35","author":"Hsu","year":"2017","journal-title":"J Clin Oncol"},{"key":"zoi210396r9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors.","volume":"10","author":"McDowell","year":"2020","journal-title":"Front Oncol"},{"key":"zoi210396r10","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104879","article-title":"Past, present and future of proton therapy for head and neck cancer.","volume":"110","author":"Li","year":"2020","journal-title":"Oral Oncol"},{"issue":"5","key":"zoi210396r11","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S1470-2045(17)30179-1","article-title":"Proton therapy for head and neck cancer: expanding the therapeutic window.","volume":"18","author":"Leeman","year":"2017","journal-title":"Lancet Oncol"},{"key":"zoi210396r12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.oraloncology.2018.11.015","article-title":"Intensity modulated proton therapy (IMPT)\u2014the future of IMRT for head and neck cancer.","volume":"88","author":"Moreno","year":"2019","journal-title":"Oral Oncol"},{"issue":"4","key":"zoi210396r13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes.","volume":"95","author":"Sio","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi210396r14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer\u2014a case matched analysis.","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"zoi210396r15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2020.03.010","article-title":"Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.","volume":"147","author":"Manzar","year":"2020","journal-title":"Radiother Oncol"},{"issue":"2","key":"zoi210396r16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2015.12.008","article-title":"Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.","volume":"118","author":"Romesser","year":"2016","journal-title":"Radiother Oncol"},{"issue":"9","key":"zoi210396r17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/cncr.32776","article-title":"Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.","volume":"126","author":"Fan","year":"2020","journal-title":"Cancer"},{"issue":"9","key":"zoi210396r18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","article-title":"Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.","volume":"15","author":"Patel","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"zoi210396r19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cncr.v126.1","article-title":"Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.","volume":"126","author":"Argirion","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"zoi210396r20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijrobp.2013.11.246","article-title":"Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.","volume":"88","author":"Stenmark","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"zoi210396r21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.14338\/IJPT-15-00011.1","article-title":"Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy.","volume":"2","author":"Holliday","year":"2015","journal-title":"Int J Particle Ther"},{"key":"zoi210396r22","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2020.1349","article-title":"Re-irradiation with moderate hypo-fractionation using intensity modulated photon or proton radiation therapy in locally recurrent squamous cell carcinoma of nasopharynx.","author":"Nam","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"9","key":"zoi210396r23","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/0284186X.2019.1622772","article-title":"Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.","volume":"58","author":"Dionisi","year":"2019","journal-title":"Acta Oncol"},{"issue":"5","key":"zoi210396r24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2015.11.047","article-title":"Global pattern of nasopharyngeal cancer: correlation of outcome with access to radiation therapy.","volume":"94","author":"Lam","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi210396r26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.radonc.2011.05.028","article-title":"Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.","volume":"101","author":"Simone","year":"2011","journal-title":"Radiother Oncol"},{"key":"zoi210396r27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1748-717X-3-4","article-title":"Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons.","volume":"3","author":"Taheri-Kadkhoda","year":"2008","journal-title":"Radiat Oncol"},{"key":"zoi210396r25","unstructured":"Particle Therapy Co-Operative Group. Particle therapy facilities under construction. Updated April 2021. Accessed April 7, 2021. https:\/\/www.ptcog.ch\/index.php\/facilities-under-construction"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2781193\/li_2021_oi_210396_1634572574.47426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:42:15Z","timestamp":1634776935000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2781193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.13205","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]}}}